Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses
Oral Oncology , 10/23/09
Saito K et al. – The authors review the development of oncolytic viruses and the clinical trials of oncolytic virotherapy for oral cancers. The authors discuss current issues and perspectives of this evolving anticancer therapy, highlighting the potential applications of a unique, naturally occurring oncolytic virus, Sindbis virus.
Related Articles
Oncolytic virus therapy for prostate cancer
International Journal of Urology, 10/15/09
Relevance Score: 42%
Enhanced specific delivery and targeting of oncolytic Sindbis viral vectors by modulating vascular leakiness in tumor
Cancer Gene Therapy, 10/07/09
Relevance Score: 42%
Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor-Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
Journal of Clinical Oncology, 11/09/09
Relevance Score: 40%
Expression of IFN-beta Enhances Both Efficacy and Safety of Oncolytic Vesicular Stomatitis Virus for Therapy of Mesothelioma
Cancer Research, 10/05/09
Relevance Score: 40%
Today in Head and Neck...keeping you current
Receive free subspecialty "5-minute updates" via email
Prognostic value of a three-grade classification in primary epithelial parotid carcinoma: Result of a histological review from a 20-year experience of total parotidectomy with neck dissection in a single institution
European Journal of Cancer, 11/25/09
Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: Results from a phase II prospective trial
Journal of Clinical Oncology, 11/25/09
Beta-tubulin-II expression strongly predicts outcome in patients receiving induction chemotherapy for locally advanced squamous carcinoma of the head and neck: A companion analysis of the TAX 324 trial
Journal of Clinical Oncology, 11/25/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Hepatoblastoma metastatic to the right atrium responding to chemotherapy alone
Pediatric Hematology and Oncology, 11/25/09
Hydroxyurea-induced hematological response in transfusion-independent beta-thalassemia intermedia: case series and review of literature
Pediatric Hematology and Oncology, 11/25/09
Bevacizumab in the treatment of breast cancer
Cancer Treatment Reviews, 11/25/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


